Correlation Between Neximmune and Windtree Therapeutics
Can any of the company-specific risk be diversified away by investing in both Neximmune and Windtree Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neximmune and Windtree Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neximmune and Windtree Therapeutics, you can compare the effects of market volatilities on Neximmune and Windtree Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neximmune with a short position of Windtree Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neximmune and Windtree Therapeutics.
Diversification Opportunities for Neximmune and Windtree Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Neximmune and Windtree is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Neximmune and Windtree Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Windtree Therapeutics and Neximmune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neximmune are associated (or correlated) with Windtree Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Windtree Therapeutics has no effect on the direction of Neximmune i.e., Neximmune and Windtree Therapeutics go up and down completely randomly.
Pair Corralation between Neximmune and Windtree Therapeutics
If you would invest (100.00) in Neximmune on December 27, 2024 and sell it today you would earn a total of 100.00 from holding Neximmune or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Neximmune vs. Windtree Therapeutics
Performance |
Timeline |
Neximmune |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Windtree Therapeutics |
Neximmune and Windtree Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Neximmune and Windtree Therapeutics
The main advantage of trading using opposite Neximmune and Windtree Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neximmune position performs unexpectedly, Windtree Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Windtree Therapeutics will offset losses from the drop in Windtree Therapeutics' long position.Neximmune vs. ZyVersa Therapeutics | Neximmune vs. Palisade Bio | Neximmune vs. Unicycive Therapeutics | Neximmune vs. Immix Biopharma |
Windtree Therapeutics vs. Palisade Bio | Windtree Therapeutics vs. Lixte Biotechnology Holdings | Windtree Therapeutics vs. Avenue Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |